期刊
MITOCHONDRION
卷 19, 期 -, 页码 85-87出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.mito.2014.04.011
关键词
Apoptosis; Mitochondria; Cell death; PI3K/Akt/mTOR; BH3 mimetics
资金
- Deutsche Forschungsgemeinschaft
- Ministerium fur Bildung und Forschung [01GM1104C]
- IUAP
- Deutsche Krebshilfe
Small-molecule inhibitors that antagonize anti-apoptotic BcI-2 proteins such as BH3 mimetics are currently considered as promising cancer therapeutics to engage the mitochondrial pathway of apoptosis in cancer cells. However, BH3 mimetics may be effective as monotherapy only in cancers that critically depend on anti-apoptotic Bc1-2 proteins for their survival. Since most cancers have evolved multiple strategies to evade programmed cell death, concomitant targeting of several signaling transduction pathways becomes more and more relevant. The current review highlights the potential of combined inhibition of anti-apoptotic BcI-2 proteins together with the PI3K/Akt/mTOR signaling cascade to trigger apoptosis in cancer cells. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据